Arbutus Biopharma Corporation (ABUS): Yep we waited for 5 years for that...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Arbutus Biopharma Corporation (ABUS)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1067
Posts	141746
Boards Moderated	14
Alias Born	03/31/2006

Re: db7 post# 6770

Monday, 03/09/2026 1:37:14 PM

Monday, March 09, 2026 1:37:14 PM

Yep we waited for 5 years for that...

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ABUS News

Arbutus Shares Jump After FDA Grants Fast Track Status to Hepatitis B Therapy • IH Market News • 04/15/2026 02:09:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 11:31:20 AM
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B • GlobeNewswire Inc. • 04/15/2026 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2026 09:05:20 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/14/2026 09:02:17 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/13/2026 11:56:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:10 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 11:30:44 AM
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute • IH Market News • 03/04/2026 11:24:49 AM
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:01:31 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:34 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 12:41:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 01:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 12:31:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 12:31:10 PM
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2025 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 12:01:34 PM
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025 • GlobeNewswire Inc. • 10/07/2025 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2025 01:00:46 PM

More ABUS News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow